Edesa Biotech
EDSA
22 hedge funds and large institutions have $1.63M invested in Edesa Biotech in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
0.21% less ownership
Funds ownership: 1.6% → 1.39% (-0.21%)
15% less funds holding
Funds holding: 26 → 22 (-4)
21% less capital invested
Capital invested by funds: $2.05M → $1.63M (-$423K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$51.9K |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$47.5K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
-$262K |
| 2 |
Renaissance Technologies
New York
|
-$16K |
| 3 |
Two Sigma Investments
New York
|
-$14.4K |
| 4 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$9.12K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$6.39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$32 | -5 | Closed |
|
EDSA Hedge Fund Activity: Q2 2023 in Review
22 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2023, worth a combined $1.63M — down 21% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of EDSA and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was CIBC World Market, opening a new position worth an estimated $51.9K. The largest seller was Lynwood Capital Management, exiting entirely with an estimated $262K sold.
- 22 institutional investors held Edesa Biotech (EDSA) as of Q2 2023, down from 26 in Q1 2023.
- Funds reported $1.63M of Edesa Biotech stock for Q2 2023, down 21% quarter-over-quarter.
- 1 fund opened new Edesa Biotech positions in Q2 2023 and 5 closed out, a net change of -4 holders.
- The largest Edesa Biotech buyer in Q2 2023 was CIBC World Market, an estimated $51.9K added.
- The largest Edesa Biotech seller in Q2 2023 was Lynwood Capital Management, an estimated $262K sold.
Based on aggregated 13F filings for Q2 2023.